Print Page

Medicine recalls

 
The United States: Recall of Warfarin Sodium Tablets (Jantoven) 3mg - Mislabeled bottles containing higher dosage
 
Upsher-Smith Laboratories and FDA notified healthcare professionals of the recall of one lot of Jantoven Warfarin Sodium, USP, 3mg Tablets, an anticoagulant, after a single bottle labeled as Jantoven Warfarin Sodium, USP, 3mg Tablets was found to contain tablets at a higher 10mg strength. The recalled lot is numbered as #284081, with an expiration date of September 2012.

Please refer to the following website in FDA for details: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm243850.htm

In Hong Kong, there is no record of registration for the above products.


Ends/ Friday, February 18, 2011
Issued at HKT 15:30
 
Related Information:
The United States: Upsher-Smith Laboratories announces expansion of recall - pro... Posted 2011-02-21
United States recalling Jantoven Warfarin Sodium 3mg Tablets Posted 2011-02-18
 
back